Board of Trustees of The Leland Stanford Junior University’s Lyell Immunopharma LYEL Stock Holding History

Board of Trustees of The Leland Stanford Junior University’s Portfolio LYEL Stock Details LYEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-82,394	Closed	-$10.7M	–	53
2022 Q2	$10.7M	Hold	82,394	–	–	0.72%	11
2022 Q1	$8.32M	Hold	82,394	–	–	0.47%	11
2021 Q4	$12.8M	Hold	82,394	–	–	0.8%	12
2021 Q3	$24.4M	Hold	82,394	–	–	1.82%	10
2021 Q2	$26.8M	Buy	+82,394	New	+$27M	2.5%	7

Other funds holding LYEL

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University's LYEL Position: Q3 2022 in Review

Board of Trustees of The Leland Stanford Junior University sold out of Lyell Immunopharma (LYEL) in Q3 2022, closing a stake of 82,394 shares — an estimated $10.7M sold.

Board of Trustees of The Leland Stanford Junior University first reported a position in LYEL in Q2 2021 and held it in 5 quarters. The position peaked at $26.8M in Q2 2021. 93 funds tracked by Wall St. Rank hold LYEL as of Q3 2022.

Board of Trustees of The Leland Stanford Junior University reported no remaining Lyell Immunopharma position as of Q3 2022 after selling out during the quarter.
Board of Trustees of The Leland Stanford Junior University sold 82,394 Lyell Immunopharma shares in Q3 2022, an estimated $10.7M.
Board of Trustees of The Leland Stanford Junior University first reported a position in Lyell Immunopharma in Q2 2021 and held it in 5 quarters.
Board of Trustees of The Leland Stanford Junior University's Lyell Immunopharma position peaked at $26.8M in Q2 2021.
93 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q3 2022.

Based on Board of Trustees of The Leland Stanford Junior University's 13F filing for Q3 2022, filed 14 Nov 2022.